Terence R. Flotte, MD
Celia and Isaac Haidak Professor, Dean of the T.H. Chan School of Medicine
Provost and Executive Deputy Chancellor
About the deanTerence R. Flotte, MD, is provost, dean and executive deputy chancellor of UMass Chan Medical School, the only public medical school in Massachusetts. Since joining UMass Chan in 2007, Dr. Flotte has forged a path of unprecedented growth and achievement for the research, education and academic missions of the campus. An internationally known scientist, Flotte has conducted research on cutting edge molecular therapeutics that led to the first successful gene transfer with adeno-associated virus (AAV) in animals and the first ever human trial of an AAV. He also led the first human recombinant AAV trials in alpha-1 antitrypsin deficiency and Tay-Sachs disease, with the latter showing promising clinical benefits. He is the author of more than 280 scholarly papers and his research has been funded by the National Institutes of Health and the Alpha One Foundation. Since 2015, Flotte has also been editor-in-chief of gene therapy’s oldest journal family, Human Gene Therapy. |
-
Read more
-
Match Day 2024 at UMass Chan: ‘Excited about the future . . . and the patients I will serve’
Read more -
Dean Flotte testifies at congressional hearing in support of gene therapy development
Read more -
New issue of @umasschan magazine highlights stories of gene therapy ‘heroes’
Read more -
Top story: Family connects with researchers behind Canavan gene therapy
Read more -
Top story: UMass Chan best in New England for primary care education
Read more -
Top story: UMass Chan-Lahey regional medical school campus approved by LCME
Read more -
UMass Chan Medical School joins ARPA-H Investor Catalyst Hub and Spoke Consortium
Read more -
UMass Chan medical students to be trained in special health care needs of veterans
Read more -
Diversity Summit at UMass Chan highlights work toward fostering inclusive culture
Read more